RNAi Technology - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

• Description
• Table of Contents
• Table of Figures
• PDF Download

• Description
• Table of Contents
• Table of Figures
• PDF Download

RNA interference is a relatively new concept in the field of medicine. It is a process in which the ribonucleic acid inhibits translation or gene expression by converting single-stranded mRNA to double stranded RNA, thereby neutralizing the target nucleic acids.

The global market for RNAi Technology was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.

As an important force driving a new round of scientific and technological revolution, artificial intelligence has been of national strategic importance. Many governments introduces polices and increase capital investment to support AI companies. The Digital Europe plan adopted by the European Union will allocate €9.2 billion on high-tech investments, such as supercomputing, artificial intelligence, and network security. In order to maintain its leading position, the United States will increase its investment in artificial intelligence research and development in non-defense fields, from US$1.6 billion to US$1.7 billion in 2022. According to the latest data released by IDC, global artificial intelligence revenue was US$432.8 billion in 2022, a year-on-year increase of 19.97%, including software, hardware and services.

Report Scope
This report aims to provide a comprehensive presentation of the global market for RNAi Technology, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of RNAi Technology by region & country, by Type, and by Application.

The RNAi Technology market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding RNAi Technology.

Market Segmentation

Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of RNAi Technology manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of RNAi Technology in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of RNAi Technology in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

 1 Market Overview
    1.1 RNAi Technology Product Introduction
    1.2 Global RNAi Technology Market Size Forecast
    1.3 RNAi Technology Market Trends & Drivers
        1.3.1 RNAi Technology Industry Trends
        1.3.2 RNAi Technology Market Drivers & Opportunity
        1.3.3 RNAi Technology Market Challenges
        1.3.4 RNAi Technology Market Restraints
    1.4 Assumptions and Limitations
    1.5 Study Objectives
    1.6 Years Considered

 2 Competitive Analysis by Company
    2.1 Global RNAi Technology Players Revenue Ranking (2023)
    2.2 Global RNAi Technology Revenue by Company (2019-2024)
    2.3 Key Companies RNAi Technology Manufacturing Base Distribution and Headquarters
    2.4 Key Companies RNAi Technology Product Offered
    2.5 Key Companies Time to Begin Mass Production of RNAi Technology
    2.6 RNAi Technology Market Competitive Analysis
        2.6.1 RNAi Technology Market Concentration Rate (2019-2024)
        2.6.2 Global 5 and 10 Largest Companies by RNAi Technology Revenue in 2023
        2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in RNAi Technology as of 2023)
    2.7 Mergers & Acquisitions, Expansion

 3 Segmentation by Type
    3.1 Introduction by Type
        3.1.1 Cancer
        3.1.2 Liver Disorders
        3.1.3 Respiratory Disorders
        3.1.4 Neurological Disorders
        3.1.5 Autoimmune Disorders
        3.1.6 Others
    3.2 Global RNAi Technology Sales Value by Type
        3.2.1 Global RNAi Technology Sales Value by Type (2019 VS 2023 VS 2030)
        3.2.2 Global RNAi Technology Sales Value, by Type (2019-2030)
        3.2.3 Global RNAi Technology Sales Value, by Type (%) (2019-2030)

 4 Segmentation by Application
    4.1 Introduction by Application
        4.1.1 Drug Discovery & Development
        4.1.2 Therapeutics
        4.1.3 Drug Delivery
        4.1.4 Others
    4.2 Global RNAi Technology Sales Value by Application
        4.2.1 Global RNAi Technology Sales Value by Application (2019 VS 2023 VS 2030)
        4.2.2 Global RNAi Technology Sales Value, by Application (2019-2030)
        4.2.3 Global RNAi Technology Sales Value, by Application (%) (2019-2030)

 5 Segmentation by Region
    5.1 Global RNAi Technology Sales Value by Region
        5.1.1 Global RNAi Technology Sales Value by Region: 2019 VS 2023 VS 2030
        5.1.2 Global RNAi Technology Sales Value by Region (2019-2024)
        5.1.3 Global RNAi Technology Sales Value by Region (2025-2030)
        5.1.4 Global RNAi Technology Sales Value by Region (%), (2019-2030)
    5.2 North America
        5.2.1 North America RNAi Technology Sales Value, 2019-2030
        5.2.2 North America RNAi Technology Sales Value by Country (%), 2023 VS 2030
    5.3 Europe
        5.3.1 Europe RNAi Technology Sales Value, 2019-2030
        5.3.2 Europe RNAi Technology Sales Value by Country (%), 2023 VS 2030
    5.4 Asia Pacific
        5.4.1 Asia Pacific RNAi Technology Sales Value, 2019-2030
        5.4.2 Asia Pacific RNAi Technology Sales Value by Country (%), 2023 VS 2030
    5.5 South America
        5.5.1 South America RNAi Technology Sales Value, 2019-2030
        5.5.2 South America RNAi Technology Sales Value by Country (%), 2023 VS 2030
    5.6 Middle East & Africa
        5.6.1 Middle East & Africa RNAi Technology Sales Value, 2019-2030
        5.6.2 Middle East & Africa RNAi Technology Sales Value by Country (%), 2023 VS 2030

 6 Segmentation by Key Countries/Regions
    6.1 Key Countries/Regions RNAi Technology Sales Value Growth Trends, 2019 VS 2023 VS 2030
    6.2 Key Countries/Regions RNAi Technology Sales Value
    6.3 United States
        6.3.1 United States RNAi Technology Sales Value, 2019-2030
        6.3.2 United States RNAi Technology Sales Value by Type (%), 2023 VS 2030
        6.3.3 United States RNAi Technology Sales Value by Application, 2023 VS 2030
    6.4 Europe
        6.4.1 Europe RNAi Technology Sales Value, 2019-2030
        6.4.2 Europe RNAi Technology Sales Value by Type (%), 2023 VS 2030
        6.4.3 Europe RNAi Technology Sales Value by Application, 2023 VS 2030
    6.5 China
        6.5.1 China RNAi Technology Sales Value, 2019-2030
        6.5.2 China RNAi Technology Sales Value by Type (%), 2023 VS 2030
        6.5.3 China RNAi Technology Sales Value by Application, 2023 VS 2030
    6.6 Japan
        6.6.1 Japan RNAi Technology Sales Value, 2019-2030
        6.6.2 Japan RNAi Technology Sales Value by Type (%), 2023 VS 2030
        6.6.3 Japan RNAi Technology Sales Value by Application, 2023 VS 2030
    6.7 South Korea
        6.7.1 South Korea RNAi Technology Sales Value, 2019-2030
        6.7.2 South Korea RNAi Technology Sales Value by Type (%), 2023 VS 2030
        6.7.3 South Korea RNAi Technology Sales Value by Application, 2023 VS 2030
    6.8 Southeast Asia
        6.8.1 Southeast Asia RNAi Technology Sales Value, 2019-2030
        6.8.2 Southeast Asia RNAi Technology Sales Value by Type (%), 2023 VS 2030
        6.8.3 Southeast Asia RNAi Technology Sales Value by Application, 2023 VS 2030
    6.9 India
        6.9.1 India RNAi Technology Sales Value, 2019-2030
        6.9.2 India RNAi Technology Sales Value by Type (%), 2023 VS 2030
        6.9.3 India RNAi Technology Sales Value by Application, 2023 VS 2030

 7 Company Profiles
    7.1 Alnylam Pharmaceuticals
        7.1.1 Alnylam Pharmaceuticals Profile
        7.1.2 Alnylam Pharmaceuticals Main Business
        7.1.3 Alnylam Pharmaceuticals RNAi Technology Products, Services and Solutions
        7.1.4 Alnylam Pharmaceuticals RNAi Technology Revenue (US$ Million) & (2019-2024)
        7.1.5 Alnylam Pharmaceuticals Recent Developments
    7.2 Dicerna Pharmaceuticals, Inc.
        7.2.1 Dicerna Pharmaceuticals, Inc. Profile
        7.2.2 Dicerna Pharmaceuticals, Inc. Main Business
        7.2.3 Dicerna Pharmaceuticals, Inc. RNAi Technology Products, Services and Solutions
        7.2.4 Dicerna Pharmaceuticals, Inc. RNAi Technology Revenue (US$ Million) & (2019-2024)
        7.2.5 Dicerna Pharmaceuticals, Inc. Recent Developments
    7.3 Arrowhead Pharmaceuticals, Inc.
        7.3.1 Arrowhead Pharmaceuticals, Inc. Profile
        7.3.2 Arrowhead Pharmaceuticals, Inc. Main Business
        7.3.3 Arrowhead Pharmaceuticals, Inc. RNAi Technology Products, Services and Solutions
        7.3.4 Arrowhead Pharmaceuticals, Inc. RNAi Technology Revenue (US$ Million) & (2019-2024)
        7.3.5 Ionis Pharmaceuticals, Inc. Recent Developments
    7.4 Ionis Pharmaceuticals, Inc.
        7.4.1 Ionis Pharmaceuticals, Inc. Profile
        7.4.2 Ionis Pharmaceuticals, Inc. Main Business
        7.4.3 Ionis Pharmaceuticals, Inc. RNAi Technology Products, Services and Solutions
        7.4.4 Ionis Pharmaceuticals, Inc. RNAi Technology Revenue (US$ Million) & (2019-2024)
        7.4.5 Ionis Pharmaceuticals, Inc. Recent Developments
    7.5 Quark Pharmaceuticals, Inc.
        7.5.1 Quark Pharmaceuticals, Inc. Profile
        7.5.2 Quark Pharmaceuticals, Inc. Main Business
        7.5.3 Quark Pharmaceuticals, Inc. RNAi Technology Products, Services and Solutions
        7.5.4 Quark Pharmaceuticals, Inc. RNAi Technology Revenue (US$ Million) & (2019-2024)
        7.5.5 Quark Pharmaceuticals, Inc. Recent Developments
    7.6 Arbutus Biopharma
        7.6.1 Arbutus Biopharma Profile
        7.6.2 Arbutus Biopharma Main Business
        7.6.3 Arbutus Biopharma RNAi Technology Products, Services and Solutions
        7.6.4 Arbutus Biopharma RNAi Technology Revenue (US$ Million) & (2019-2024)
        7.6.5 Arbutus Biopharma Recent Developments
    7.7 Benitec Biopharma
        7.7.1 Benitec Biopharma Profile
        7.7.2 Benitec Biopharma Main Business
        7.7.3 Benitec Biopharma RNAi Technology Products, Services and Solutions
        7.7.4 Benitec Biopharma RNAi Technology Revenue (US$ Million) & (2019-2024)
        7.7.5 Benitec Biopharma Recent Developments
    7.8 Calando
        7.8.1 Calando Profile
        7.8.2 Calando Main Business
        7.8.3 Calando RNAi Technology Products, Services and Solutions
        7.8.4 Calando RNAi Technology Revenue (US$ Million) & (2019-2024)
        7.8.5 Calando Recent Developments
    7.9 Silence Therapeutics
        7.9.1 Silence Therapeutics Profile
        7.9.2 Silence Therapeutics Main Business
        7.9.3 Silence Therapeutics RNAi Technology Products, Services and Solutions
        7.9.4 Silence Therapeutics RNAi Technology Revenue (US$ Million) & (2019-2024)
        7.9.5 Silence Therapeutics Recent Developments
    7.10 Gotham Therapeutics
        7.10.1 Gotham Therapeutics Profile
        7.10.2 Gotham Therapeutics Main Business
        7.10.3 Gotham Therapeutics RNAi Technology Products, Services and Solutions
        7.10.4 Gotham Therapeutics RNAi Technology Revenue (US$ Million) & (2019-2024)
        7.10.5 Gotham Therapeutics Recent Developments

 8 Industry Chain Analysis
    8.1 RNAi Technology Industrial Chain
    8.2 RNAi Technology Upstream Analysis
        8.2.1 Key Raw Materials
        8.2.2 Raw Materials Key Suppliers
        8.2.3 Manufacturing Cost Structure
    8.3 Midstream Analysis
    8.4 Downstream Analysis (Customers Analysis)
    8.5 Sales Model and Sales Channels
        8.5.1 RNAi Technology Sales Model
        8.5.2 Sales Channel
        8.5.3 RNAi Technology Distributors

 9 Research Findings and Conclusion

 10 Appendix
    10.1 Research Methodology
        10.1.1 Methodology/Research Approach
        10.1.2 Data Source
    10.2 Author Details
    10.3 Disclaimer

List of Tables
    Table 1. RNAi Technology Market Trends
    Table 2. RNAi Technology Market Drivers & Opportunity
    Table 3. RNAi Technology Market Challenges
    Table 4. RNAi Technology Market Restraints
    Table 5. Global RNAi Technology Revenue by Company (2019-2024) & (US$ Million)
    Table 6. Global RNAi Technology Revenue Market Share by Company (2019-2024)
    Table 7. Key Companies RNAi Technology Manufacturing Base Distribution and Headquarters
    Table 8. Key Companies RNAi Technology Product Type
    Table 9. Key Companies Time to Begin Mass Production of RNAi Technology
    Table 10. Global RNAi Technology Companies Market Concentration Ratio (CR5 and HHI)
    Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in RNAi Technology as of 2023)
    Table 12. Mergers & Acquisitions, Expansion Plans
    Table 13. Global RNAi Technology Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
    Table 14. Global RNAi Technology Sales Value by Type (2019-2024) & (US$ Million)
    Table 15. Global RNAi Technology Sales Value by Type (2025-2030) & (US$ Million)
    Table 16. Global RNAi Technology Sales Market Share in Value by Type (2019-2024) & (%)
    Table 17. Global RNAi Technology Sales Market Share in Value by Type (2025-2030) & (%)
    Table 18. Global RNAi Technology Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
    Table 19. Global RNAi Technology Sales Value by Application (2019-2024) & (US$ Million)
    Table 20. Global RNAi Technology Sales Value by Application (2025-2030) & (US$ Million)
    Table 21. Global RNAi Technology Sales Market Share in Value by Application (2019-2024) & (%)
    Table 22. Global RNAi Technology Sales Market Share in Value by Application (2025-2030) & (%)
    Table 23. Global RNAi Technology Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 24. Global RNAi Technology Sales Value by Region (2019-2024) & (US$ Million)
    Table 25. Global RNAi Technology Sales Value by Region (2025-2030) & (US$ Million)
    Table 26. Global RNAi Technology Sales Value by Region (2019-2024) & (%)
    Table 27. Global RNAi Technology Sales Value by Region (2025-2030) & (%)
    Table 28. Key Countries/Regions RNAi Technology Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
    Table 29. Key Countries/Regions RNAi Technology Sales Value, (2019-2024) & (US$ Million)
    Table 30. Key Countries/Regions RNAi Technology Sales Value, (2025-2030) & (US$ Million)
    Table 31. Alnylam Pharmaceuticals Basic Information List
    Table 32. Alnylam Pharmaceuticals Description and Business Overview
    Table 33. Alnylam Pharmaceuticals RNAi Technology Products, Services and Solutions
    Table 34. Revenue (US$ Million) in RNAi Technology Business of Alnylam Pharmaceuticals (2019-2024)
    Table 35. Alnylam Pharmaceuticals Recent Developments
    Table 36. Dicerna Pharmaceuticals, Inc. Basic Information List
    Table 37. Dicerna Pharmaceuticals, Inc. Description and Business Overview
    Table 38. Dicerna Pharmaceuticals, Inc. RNAi Technology Products, Services and Solutions
    Table 39. Revenue (US$ Million) in RNAi Technology Business of Dicerna Pharmaceuticals, Inc. (2019-2024)
    Table 40. Dicerna Pharmaceuticals, Inc. Recent Developments
    Table 41. Arrowhead Pharmaceuticals, Inc. Basic Information List
    Table 42. Arrowhead Pharmaceuticals, Inc. Description and Business Overview
    Table 43. Arrowhead Pharmaceuticals, Inc. RNAi Technology Products, Services and Solutions
    Table 44. Revenue (US$ Million) in RNAi Technology Business of Arrowhead Pharmaceuticals, Inc. (2019-2024)
    Table 45. Arrowhead Pharmaceuticals, Inc. Recent Developments
    Table 46. Ionis Pharmaceuticals, Inc. Basic Information List
    Table 47. Ionis Pharmaceuticals, Inc. Description and Business Overview
    Table 48. Ionis Pharmaceuticals, Inc. RNAi Technology Products, Services and Solutions
    Table 49. Revenue (US$ Million) in RNAi Technology Business of Ionis Pharmaceuticals, Inc. (2019-2024)
    Table 50. Ionis Pharmaceuticals, Inc. Recent Developments
    Table 51. Quark Pharmaceuticals, Inc. Basic Information List
    Table 52. Quark Pharmaceuticals, Inc. Description and Business Overview
    Table 53. Quark Pharmaceuticals, Inc. RNAi Technology Products, Services and Solutions
    Table 54. Revenue (US$ Million) in RNAi Technology Business of Quark Pharmaceuticals, Inc. (2019-2024)
    Table 55. Quark Pharmaceuticals, Inc. Recent Developments
    Table 56. Arbutus Biopharma Basic Information List
    Table 57. Arbutus Biopharma Description and Business Overview
    Table 58. Arbutus Biopharma RNAi Technology Products, Services and Solutions
    Table 59. Revenue (US$ Million) in RNAi Technology Business of Arbutus Biopharma (2019-2024)
    Table 60. Arbutus Biopharma Recent Developments
    Table 61. Benitec Biopharma Basic Information List
    Table 62. Benitec Biopharma Description and Business Overview
    Table 63. Benitec Biopharma RNAi Technology Products, Services and Solutions
    Table 64. Revenue (US$ Million) in RNAi Technology Business of Benitec Biopharma (2019-2024)
    Table 65. Benitec Biopharma Recent Developments
    Table 66. Calando Basic Information List
    Table 67. Calando Description and Business Overview
    Table 68. Calando RNAi Technology Products, Services and Solutions
    Table 69. Revenue (US$ Million) in RNAi Technology Business of Calando (2019-2024)
    Table 70. Calando Recent Developments
    Table 71. Silence Therapeutics Basic Information List
    Table 72. Silence Therapeutics Description and Business Overview
    Table 73. Silence Therapeutics RNAi Technology Products, Services and Solutions
    Table 74. Revenue (US$ Million) in RNAi Technology Business of Silence Therapeutics (2019-2024)
    Table 75. Silence Therapeutics Recent Developments
    Table 76. Gotham Therapeutics Basic Information List
    Table 77. Gotham Therapeutics Description and Business Overview
    Table 78. Gotham Therapeutics RNAi Technology Products, Services and Solutions
    Table 79. Revenue (US$ Million) in RNAi Technology Business of Gotham Therapeutics (2019-2024)
    Table 80. Gotham Therapeutics Recent Developments
    Table 81. Key Raw Materials Lists
    Table 82. Raw Materials Key Suppliers Lists
    Table 83. RNAi Technology Downstream Customers
    Table 84. RNAi Technology Distributors List
    Table 85. Research Programs/Design for This Report
    Table 86. Key Data Information from Secondary Sources
    Table 87. Key Data Information from Primary Sources
    Table 88. Business Unit and Senior & Team Lead Analysts
List of Figures
    Figure 1. RNAi Technology Product Picture
    Figure 2. Global RNAi Technology Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global RNAi Technology Sales Value (2019-2030) & (US$ Million)
    Figure 4. RNAi Technology Report Years Considered
    Figure 5. Global RNAi Technology Players Revenue Ranking (2023) & (US$ Million)
    Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by RNAi Technology Revenue in 2023
    Figure 7. RNAi Technology Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 8. Cancer Picture
    Figure 9. Liver Disorders Picture
    Figure 10. Respiratory Disorders Picture
    Figure 11. Neurological Disorders Picture
    Figure 12. Autoimmune Disorders Picture
    Figure 13. Others Picture
    Figure 14. Global RNAi Technology Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 15. Global RNAi Technology Sales Value Market Share by Type, 2023 & 2030
    Figure 16. Product Picture of Drug Discovery & Development
    Figure 17. Product Picture of Therapeutics
    Figure 18. Product Picture of Drug Delivery
    Figure 19. Product Picture of Others
    Figure 20. Global RNAi Technology Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 21. Global RNAi Technology Sales Value Market Share by Application, 2023 & 2030
    Figure 22. North America RNAi Technology Sales Value (2019-2030) & (US$ Million)
    Figure 23. North America RNAi Technology Sales Value by Country (%), 2023 VS 2030
    Figure 24. Europe RNAi Technology Sales Value (2019-2030) & (US$ Million)
    Figure 25. Europe RNAi Technology Sales Value by Country (%), 2023 VS 2030
    Figure 26. Asia Pacific RNAi Technology Sales Value (2019-2030) & (US$ Million)
    Figure 27. Asia Pacific RNAi Technology Sales Value by Country (%), 2023 VS 2030
    Figure 28. South America RNAi Technology Sales Value (2019-2030) & (US$ Million)
    Figure 29. South America RNAi Technology Sales Value by Country (%), 2023 VS 2030
    Figure 30. Middle East & Africa RNAi Technology Sales Value (2019-2030) & (US$ Million)
    Figure 31. Middle East & Africa RNAi Technology Sales Value by Country (%), 2023 VS 2030
    Figure 32. Key Countries/Regions RNAi Technology Sales Value (%), (2019-2030)
    Figure 33. United States RNAi Technology Sales Value, (2019-2030) & (US$ Million)
    Figure 34. United States RNAi Technology Sales Value by Type (%), 2023 VS 2030
    Figure 35. United States RNAi Technology Sales Value by Application (%), 2023 VS 2030
    Figure 36. Europe RNAi Technology Sales Value, (2019-2030) & (US$ Million)
    Figure 37. Europe RNAi Technology Sales Value by Type (%), 2023 VS 2030
    Figure 38. Europe RNAi Technology Sales Value by Application (%), 2023 VS 2030
    Figure 39. China RNAi Technology Sales Value, (2019-2030) & (US$ Million)
    Figure 40. China RNAi Technology Sales Value by Type (%), 2023 VS 2030
    Figure 41. China RNAi Technology Sales Value by Application (%), 2023 VS 2030
    Figure 42. Japan RNAi Technology Sales Value, (2019-2030) & (US$ Million)
    Figure 43. Japan RNAi Technology Sales Value by Type (%), 2023 VS 2030
    Figure 44. Japan RNAi Technology Sales Value by Application (%), 2023 VS 2030
    Figure 45. South Korea RNAi Technology Sales Value, (2019-2030) & (US$ Million)
    Figure 46. South Korea RNAi Technology Sales Value by Type (%), 2023 VS 2030
    Figure 47. South Korea RNAi Technology Sales Value by Application (%), 2023 VS 2030
    Figure 48. Southeast Asia RNAi Technology Sales Value, (2019-2030) & (US$ Million)
    Figure 49. Southeast Asia RNAi Technology Sales Value by Type (%), 2023 VS 2030
    Figure 50. Southeast Asia RNAi Technology Sales Value by Application (%), 2023 VS 2030
    Figure 51. India RNAi Technology Sales Value, (2019-2030) & (US$ Million)
    Figure 52. India RNAi Technology Sales Value by Type (%), 2023 VS 2030
    Figure 53. India RNAi Technology Sales Value by Application (%), 2023 VS 2030
    Figure 54. RNAi Technology Industrial Chain
    Figure 55. RNAi Technology Manufacturing Cost Structure
    Figure 56. Channels of Distribution (Direct Sales, and Distribution)
    Figure 57. Bottom-up and Top-down Approaches for This Report
    Figure 58. Data Triangulation

RNA interference is a relatively new concept in the field of medicine. It is a process in which the ribonucleic acid inhibits translation or gene expression by converting single-stranded mRNA to double stranded RNA, thereby neutralizing the target nucleic acids.

The global market for RNAi Technology was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.

As an important force driving a new round of scientific and technological revolution, artificial intelligence has been of national strategic importance. Many governments introduces polices and increase capital investment to support AI companies. The Digital Europe plan adopted by the European Union will allocate €9.2 billion on high-tech investments, such as supercomputing, artificial intelligence, and network security. In order to maintain its leading position, the United States will increase its investment in artificial intelligence research and development in non-defense fields, from US$1.6 billion to US$1.7 billion in 2022. According to the latest data released by IDC, global artificial intelligence revenue was US$432.8 billion in 2022, a year-on-year increase of 19.97%, including software, hardware and services.

Report Scope
This report aims to provide a comprehensive presentation of the global market for RNAi Technology, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of RNAi Technology by region & country, by Type, and by Application.

The RNAi Technology market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding RNAi Technology.

Market Segmentation

Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of RNAi Technology manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of RNAi Technology in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of RNAi Technology in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.